The Norwegian Medicines Agency said in a statement that 13 of the dead had been autopsied. It is thought that mRNA vaccines may have killed people with common side effects such as fever, nausea and diarrhea.
These common reactions can be unfavorable for older people, says Steiner Madsen. However, it is not dangerous for healthy strong people. Vaccine reactions are not uncommon. We are not worried or worried about this. Because these are very rare cases. These occur in the body of extremely serious patients.
The Norwegian government and the Norwegian Institute of Public Health have updated the coroner's immunization policy with more detailed advice on immunizing the elderly after 23 deaths in Norway. Physicians will now evaluate the risks of giving the corona vaccine to patients and the side effects of the vaccine to very weak patients.
Norway has vaccinated more than 30,000 people against corona in the past few weeks. The country's health regulator says an average of 400 people die each week in nursing homes and long-term care providers. The Norwegian Medicines Agency says it is vaccinating the elderly in Norway and the elderly in a nursing home with a serious illness. It is hoped, therefore, that deaths may occur near the time of vaccination. All deaths occurring within the first few days of vaccination have been carefully assessed.
As of Thursday, January 14, 23 reports of suspicious deaths had been submitted to Norway's ADR Health Registry. Several reports of suspected adverse reactions are being received daily. These are constantly being evaluated.
Pfizer said in a statement to Bloomberg that the agency was working with the country's health regulator. What has happened so far is not 'worrying'. These events are consistent with their expectations.
Yay! 🤗
Your post has been boosted with Ecency Points.
Continue earning Points just by using https://ecency.com, every action is rewarded (being online, posting, commenting, reblog, vote and more).
Support Ecency, check our proposal:
Ecency: https://ecency.com/proposals/141
Hivesigner: Vote for Proposal